Literature DB >> 11516501

Pegylation enhances protein stability during encapsulation in PLGA microspheres.

M Diwan1, T G Park.   

Abstract

During encapsulation of proteins in biodegradable microspheres, a significant amount of the protein reportedly undergoes denaturation to form irreversible insoluble aggregates. Incomplete in vitro release of proteins from the microspheres is a common observation. An attempt was made to overcome this problem by pegylation of the protein to be encapsulated. Lysozyme, a model protein, was conjugated with methoxy polyethylene glycol (mPEG, MW 5000). The conjugate was characterized by SDS-PAGE, SE-HPLC, and MALDI-TOF mass spectroscopy. The pegylated lysozyme (Lys-mPEG) consisted of different isomers of mono-, di- and tri-pegylated with about 15% as native lysozyme. The specific activity of the protein was retained after pegylation (101.3+/-10.4%). The microsphere encapsulation process was simulated for pegylated and native lysozyme. Pegylated lysozyme exhibited much better stability than native lysozyme against exposure to organic solvent (dichloromethane), homogenization, and showed reduced adsorption onto the surface of blank PLGA microspheres. Release profiles of the two proteins from microspheres were very different. For native lysozyme, it was high initial release (about 50%) followed by a nearly no release (about 10% in 50 days). In contrast, Lys-mPEG conjugate showed a triphasic and near complete release over 83 days. This study shows that the pegylation of protein can provide substantial protection against the destabilization of protein during encapsulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516501     DOI: 10.1016/s0168-3659(01)00292-9

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

Review 1.  Non-invasive administration of biodegradable nano-carrier vaccines.

Authors:  Mohd Abul Kalam; Abdul Arif Khan; Aws Alshamsan
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

2.  EphA2 targeted intratumoral therapy for non-small cell lung cancer using albumin mesospheres.

Authors:  Hung-Yen Lee; Kamal A Mohammed; Fredric Kaye; Brij M Moudgil; Najmunnisa Nasreen
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

3.  Polymeric Nanocarrier Formulations of Biologics Using Inverse Flash NanoPrecipitation.

Authors:  Chester E Markwalter; Robert F Pagels; Ava N Hejazi; Akiva G R Gordon; Alexandra L Thompson; Robert K Prud'homme
Journal:  AAPS J       Date:  2020-01-02       Impact factor: 4.009

4.  A single dose of a DNA vaccine encoding apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against tuberculosis in Mycobacterium bovis BCG-primed mice.

Authors:  Dyego Carlétti; Denise Morais da Fonseca; Ana Flávia Gembre; Ana Paula Masson; Lívia Weijenborg Campos; Luciana C C Leite; Andréa Rodrigues Pires; Joseli Lannes-Vieira; Célio Lopes Silva; Vânia Luiza Deperon Bonato; Cynthia Horn
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

5.  Loading PEG-catalase into filamentous and spherical polymer nanocarriers.

Authors:  Eric A Simone; Thomas D Dziubla; Evguenia Arguiri; Vanessa Vardon; Vladimir V Shuvaev; Melpo Christofidou-Solomidou; Vladimir R Muzykantov
Journal:  Pharm Res       Date:  2008-10-28       Impact factor: 4.200

Review 6.  Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation.

Authors:  Mariagrazia Di Marco; Shaharum Shamsuddin; Khairunisak Abdul Razak; Azlan Abdul Aziz; Corinne Devaux; Elsa Borghi; Laurent Levy; Claudia Sadun
Journal:  Int J Nanomedicine       Date:  2010-02-02

7.  Preparation and stability of poly(ethylene glycol) (PEG)ylated octreotide for application to microsphere delivery.

Authors:  Dong Hee Na; Santos B Murty; Kang Choon Lee; B C Thanoo; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2003-12-31       Impact factor: 3.246

8.  PEGylation of interleukin-10 for the mitigation of enhanced pain states.

Authors:  Ryan G Soderquist; Erin D Milligan; Jacqueline A Harrison; Raymond A Chavez; Kirk W Johnson; Linda R Watkins; Melissa J Mahoney
Journal:  J Biomed Mater Res A       Date:  2010-06-01       Impact factor: 4.396

9.  Composite hydrogel formulations of stratifin to control MMP-1 expression in dermal fibroblasts.

Authors:  Elham Rahmani-Neishaboor; John Jackson; Helen Burt; Aziz Ghahary
Journal:  Pharm Res       Date:  2009-06-17       Impact factor: 4.200

10.  A biomimetic approach to active self-microencapsulation of proteins in PLGA.

Authors:  Ronak B Shah; Steven P Schwendeman
Journal:  J Control Release       Date:  2014-09-08       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.